1. Wu Z, Hu Y, Xu M, et al. Safety, Tolerability, And Immunogenicity Of An Inactivated SARS-CoV-2 Vaccine (CoronaVac) In Healthy Adults Aged 60 Years And Older: A Randomised, Double-Blind, Placebo-Controlled, Phase 1/2 Clinical Trial. Lancet Infect Dis [Internet]. 2021;0(0):1–9. Available from: www.thelancet.com/infectionPublishedonline
2. Zhang Y, Zeng G, Pan H, et al. Safety, Tolerability, And Immunogenicity Of An Inactivated SARS-CoV-2 Vaccine In Healthy Adults Aged 18–59 Years: A Randomised, Double-Blind, Placebo-Controlled, Phase 1/2 Clinical Trial. Lancet Infect Dis [Internet]. 2021;21(2):181–92. Available from: http://dx.doi.org/10.1016/S1473-3099(20)30843-4
3. Statistics Indonesia (Badan Pusat Statistik [BPS]). Statistik Penduduk Lanjut Usia. 2020.